Journals / Türkderm-Deri Hastalıkları ve Frengi Arşivi / 2011 / Cilt: 45 - Sayı: 1

The Turkish version of the psoriasis disability index: A validation and reliability study

Psoriasis hastalarında psoriasis işlev laybı indeksinin Türkçe geçerlilik ve güvenilirlik çalışması

Pages
24–28
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

For internal consistency, Cronbach’s alpha coefficients of all subscales ranged between 0.61 and 0.79 and were calculated as 0.88 for the overall index.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:(Türkderm 2011; 45: 24-8) Anahtar Kelimeler: Dermatoloji yaflam kalite ölçe¤i, psoriasis, psoriasis ifllev kayb› indeksi, yaflam kalitesi, türkçe versiyon Summary Background and Design: Several instruments are available for assessing impairment and disability associated with psoriasis.
📊
Key Findings & Data:Results: A total of 161 psoriasis patients were included in the study.
💡
Conclusion & Impact:For internal consistency, Cronbach’s alpha coefficients of all subscales ranged between 0.61 and 0.79 and were calculated as 0.88 for the overall index.
🔬Design:Survey & Empirical Study
📍Scope:2011 Verileri
⚙️Variables:Domain Parameters

Abstract

(Türkderm 2011; 45: 24-8) Anahtar Kelimeler: Dermatoloji yaflam kalite ölçe¤i, psoriasis, psoriasis ifllev kayb› indeksi, yaflam kalitesi, türkçe versiyon Summary Background and Design: Several instruments are available for assessing impairment and disability associated with psoriasis. The first psoriasis-specific quality of life questionnaire, Psoriasis Disability Index (PDI), has been translated to many different languages and used in studies all around the world. The aim of this study was to translate the PDI into Turkish and to validate the Turkish version of the PDI and its use for Turkish psoriasis patients, as well as to examine the specific contribution of demographic and clinical features to the PDI. Material and Method: The questionnaire was translated into Turkish by using appropriate translation steps. The socio-demographic data and the Psoriasis Area and Severity Index (PASI) scores of the patients were recorded. For reliability analysis, internal consistency and test-retest method were used. The Cronbach’s alpha coefficient and item-total statistics were calculated for each question and subscales. For validation, the questionnaire was compared with the Dermatology Life Quality Index (DLQI). Results: A total of 161 psoriasis patients were included in the study. For internal consistency, Cronbach’s alpha coefficients of all subscales ranged between 0.61 and 0.79 and were calculated as 0.88 for the overall index. In test-retest reliability, the correlation coefficient ranged between 0.366 and 0.775 for each question and were calculated as r=0.854 for the total PDI score (p

Özet

Psoriasis vulgaris, hastaların yaşam kalitesini önemli ölçüde etkileyen kronik bir hastalıktır. Hastalığa özgü geliştirilen ilk ölçek olan “Psoriasis İşlev Kaybı İndeksi” (PİKİ), pek çok dilde geçerlilik ve güvenilirliğini kanıtlamış ve klinik çalışmalarda kullanılmıştır. Bu çalışmada amacımız, PİKİ’ni Türkçeye çevirerek, dilimizde geçerliliğini ve güvenilirliğini araştırmaktı. Gereç ve Yöntem: Ölçek, uluslararası çeviri basamakları izlenerek Türkçeye çevrildi. Hastaların Psoriasis alan şiddet indeksi (PAŞİ) skorları, demografik ve klinik bulguları kaydedildi. Güvenilirlik analizi için “iç yapı tutarlılığı” ve “test-tekrar test” metotlarıkullanıldı. Ölçekteki her bir soru ve alt gruplar için Cronbach alfa katsayısı ve madde-toplam puan korelasyonları hesaplandı. Geçerlilik analizi için, “Dermatoloji Yaşam Kalite ölçeği”(DYKÖ) ile karşılaştırma yöntemi kullanıldı. Elde edilen PİKİ skorları,hastaların demografik bulguları ve klinik özellikleri ile karşılaştırıldı.Bulgular: Çalışmaya 161 psoriasis hastası alındı. İçyapı tutarlılık ölçümünde tüm alt ölçeklerin Cronbach alfa katsayısı 0,61-0,79 arasında değişmekte olup, tüm anket için 0,88 olarak hesaplandı. Test- tekrar test güvenilirliğinde, her bir soru için korelasyonkatsayısı 0,366-0,775 arasında değişmekte olup, toplam PİKİ skoru için korelasyon katsayısı r=0,854 olarak hesaplandı (p

🔖

Cite This Article

KÖŞLÜ, A., GÖKDEMİR, G., FİŞEK, N., CAN, G. (2022). The Turkish version of the psoriasis disability index: A validation and reliability study. Türkderm-Deri Hastalıkları ve Frengi Arşivi, Cilt: 45 - Sayı: 1, 24–28. https://ajindex.com/articles/621986

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Finlay AY: Quality of life measurement in dermatology: a practical guide. Br J Dermatol 1997;136:305-14
  2. McKenna SP, Lebwohl M, Kahler KN: Development of the US PSORIQoL: a psoriasis-specific measure of quality of life. Int J Dermatol 2005;44:462-9
  3. Inan›r I, Aydemir Ö, Gündüz K, Danac› AE, Türel A: Developing a quality of life instrument in patients with psoriasis: the Psoriasis Quality of Life Questionnaire (PQLQ). Int J Dermatol 2005;45:234-8
  4. Kirby B, Richards HL, Hindle E, Main CJ, Griffiths: Physical and psychologic measures are necessary to assess overall psoriasis severity. J Am Acad Dermatol 2001;45:72-6
  5. Ginsburg IH, Link BG: Psychosocial consequences of rejection and stigma feelings in psoriasis patients. Int J Dermatol 1993;32:587-91
  6. Fortune DG, Richards HL, Main CJ, Griffiths CEM: Patients’ strategies for coping with psoriasis. Clin Exp Dermatol 2002;27:177-84
  7. Fortune DG, Richards HL, Main CJ, Griffiths CEM: What patients with psoriasis believe about their condition. J Am Acad Dermatol 1998;39:196-201
  8. Rapp SR, Feldman SR, Exum ML, Fleischer AB Jr, Reboussin DM: Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol 1999;41:401-7
  9. De Arruda LH, De Moraes AP: The impact of psoriasis on quality of life. Br J Dermatol 2001;144:33-6
  10. Fortune DG, Main CJ, O'Sullivan TM, Griffiths CE: Quality of life in patients with psoriasis: The contribution of clinical variables and psoriasis-specific stress. Br J Dermatol 1997;137:755-60
  11. Finlay AY, Kelly SE: Psoriasis--an index of disability. Clin Exp Dermatol 1987;12:8-11
  12. Finlay AY, Khan GK: Dermatology Life Quality Index (DLQI)--a simple practical measure for routine clinical use. Clin Exp Dermatol 1994;19:210-6
  13. Anderson RT, Rajagopalan R, Winston S: Development and validation of a quality of life instrument for cutaneous diseases. J Am Acad Dermatol 1997;37:41-50
  14. Ashcroft DM, Li Wan Po A, Williams HC, Griffiths CE: Ash Quality of life measures in psoriasis: a critical appraisal of their quality. J Clin Pharm Ther 1998;23:391-8 15. Gupta MA, Gupta AK: The Psoriasis Life Stress Inventory: a preliminary index of psoriasis-related stress. Acta Derm Venereol 1995; 75(3): 240-3
  15. Mukhtar R, Choi J, Koo JYM: Quality of life issues in psoriasis. Dermatol Clin 2004;22:389-395
  16. Lewis VJ, Finlay AY: Two decades experience of the Psoriasis Disability Index. Dermatology 2005;210:261-8
  17. McKenna SP, Cook SA, Whalley D, et al.: